Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
GNC-035
i
Other names:
GNC-035
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Biokin Pharma
Drug class:
PD-L1 inhibitor, CD3 agonist, ROR1 inhibitor, CD137 inhibitor
Related drugs:
‹
atezolizumab (203)
durvalumab (178)
avelumab (87)
KN046 (17)
APL-502 (8)
M7824 (8)
envafolimab (4)
sugemalimab (3)
SHR-1701 (3)
SAR445710 (2)
atezolizumab SC (2)
STI-A1014 (2)
BMS-202 (1)
CCX559 (1)
EPIM-001 (1)
FS118 (1)
GI-101 (1)
INCB86550 (1)
NI-2901 (1)
Q-1802 (1)
LY3300054 (1)
blinatumomab (43)
MGD006 (6)
GEN-3013 (5)
CTIM-76 (3)
AMG 757 (3)
ASP2138 (2)
IMC-F106C (2)
mosunetuzumab (2)
NVG-111 (2)
teclistamab (2)
CC-93269 (2)
AMV564 (2)
AMG 509 (1)
HPN-217 (1)
ISB 1342 (1)
MGD024 (1)
SAR442257 (1)
PF-06863135 (1)
RG6026 (1)
REGN1979 (1)
AMG 701 (1)
JNJ-64407564 (1)
REGN4018 (1)
XmAb14045 (1)
JNJ-63898081 (1)
UC-961 (6)
atezolizumab (203)
durvalumab (178)
avelumab (87)
KN046 (17)
APL-502 (8)
M7824 (8)
envafolimab (4)
sugemalimab (3)
SHR-1701 (3)
SAR445710 (2)
atezolizumab SC (2)
STI-A1014 (2)
BMS-202 (1)
CCX559 (1)
EPIM-001 (1)
FS118 (1)
GI-101 (1)
INCB86550 (1)
NI-2901 (1)
Q-1802 (1)
LY3300054 (1)
blinatumomab (43)
MGD006 (6)
GEN-3013 (5)
CTIM-76 (3)
AMG 757 (3)
ASP2138 (2)
IMC-F106C (2)
mosunetuzumab (2)
NVG-111 (2)
teclistamab (2)
CC-93269 (2)
AMV564 (2)
AMG 509 (1)
HPN-217 (1)
ISB 1342 (1)
MGD024 (1)
SAR442257 (1)
PF-06863135 (1)
RG6026 (1)
REGN1979 (1)
AMG 701 (1)
JNJ-64407564 (1)
REGN4018 (1)
XmAb14045 (1)
JNJ-63898081 (1)
UC-961 (6)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
ROR1 positive
Lung Cancer
ROR1 positive
Lung Cancer
GNC-035
Sensitive: D – Preclinical
AACR 2023 - 1 week (New D)
GNC-035
Sensitive
:
D
AACR 2023 - 1wk
GNC-035
Sensitive: D – Preclinical
AACR 2023 - 1 week
GNC-035
Sensitive
:
D
AACR 2023 - 1 week - (New D)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login